Kardio Life
- Address
- Warszawska 15/17, 87-800 Gdansk, Poland
Kardio Life - Cardiovascular & Mental Health Research Center
Kardio Life is a specialized research center dedicated to advancing the understanding and treatment of complex cardiovascular conditions, with particular emphasis on the intersection between cardiac health and mental well-being. The center focuses on innovative therapeutic approaches for patients with heart failure and associated psychological comorbidities.
- Heart failure with preserved ejection fraction (HFpEF) management and outcomes
- Depression and anxiety in cardiovascular patient populations
- Endothelial dysfunction and cardiovascular biomarkers research
The research team at Kardio Life investigates novel treatment strategies that address both cardiac and psychological aspects of cardiovascular disease, including the therapeutic potential of selective serotonin reuptake inhibitors (SSRIs) in heart failure patients. Their work emphasizes patient-centered outcomes such as hospitalization rates and mortality reduction, while exploring the role of endothelial function and biomarkers in disease progression and treatment response.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Eli Lilly & Co.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kardio Life
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease | Eli Lilly & Co. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ziltivekimab | 2 | Unknown | 2021-09-24 | 2023-05-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.